Literature DB >> 2140896

Functional expression in vitro of bovine visual rhodopsin.

S A Zozulya1, V V Gurevich, T A Zvyaga, E P Shirokova, I L Dumler, M N Garnovskaya, B E Shmukler, P R Badalov.   

Abstract

Expression of functionally active bovine visual rhodopsin was achieved by sequential transcription and translation in vitro of rhodopsin gene cDNA with co-translational insertion of the protein into phosphatidylcholine liposomes. The recombinant rhodopsin has functional, spectral and immunochemical properties similar to those of natural rhodopsin from bovine retina. Two mutant rhodopsins, Cys316----Ser and Asp330----Asn, Asp331----Asn, were produced by oligonucleotide-directed mutagenesis. The first mutation does not affect rhodopsin's ability to stimulate transducin GTPase and visual cGMP phosphodiesterase activities, while the second double mutation leads to a sharp decrease in rhodopsin activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140896     DOI: 10.1093/protein/3.5.453

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  4 in total

1.  Point mutations in bovine opsin can be classified in four groups with respect to their effect on the biosynthetic pathway of opsin.

Authors:  G L DeCaluwé; W J DeGrip
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

2.  Phosphorylation of bovine rod photoreceptor cyclic GMP phosphodiesterase.

Authors:  I P Udovichenko; J Cunnick; K Gonzales; D J Takemoto
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

3.  Structure and function in rhodopsin: the role of asparagine-linked glycosylation.

Authors:  S Kaushal; K D Ridge; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

4.  Palmitoylation of bovine opsin and its cysteine mutants in COS cells.

Authors:  S S Karnik; K D Ridge; S Bhattacharya; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.